Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
The American Journal of Tropical Medicine and Hygiene|April 12, 2007
Induction of bivalent immune responses by expression of dengue virus type 1 and type 2 antigens from a single complex adenoviral vectorNicholas U Raja, David H Holman, Danher Wang, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 2, 2006
Four dengue virus serotypes found circulating during an outbreak of dengue fever and dengue haemorrhagic fever in Jakarta, Indonesia, during 2004Agus Suwandono, Herman Kosasih, Nurhayati, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
Influenza surveillance in Indonesia: 1999-2003Charmagne G Beckett, Herman Kosasih, Chairin Ma'roef, et al.
Virology|November 18, 2008
Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virusPeifang Sun, Stefan Fernandez, Mary A Marovich, et al.
Pathogens (Basel, Switzerland)|June 2, 2021
Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c MiceAppavu K Sundaram, Daniel Ewing, Zhaodong Liang, et al.
Tropical Diseases, Travel Medicine and Vaccines|June 11, 2020
Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glandsGuy El Helou, Todd A Ponzio, Joseph F Goodman, et al.
Vaccine|November 30, 2010
Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trialCharmagne G Beckett, Jeffrey Tjaden, Timothy Burgess, et al.
Plos Neglected Tropical Diseases|November 9, 2013
Evidence for endemic chikungunya virus infections in Bandung, IndonesiaHerman Kosasih, Quirijn de Mast, Susana Widjaja, et al.
The American Journal of Tropical Medicine and Hygiene|June 22, 2005
Early detection of dengue infections using cluster sampling around index casesCharmagne G Beckett, Herman Kosasih, Indra Faisal, et al.
Vaccines|May 25, 2024
Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman PrimatesJohn W Sanders, Daniel Ewing, Appavu K Sundaram, et al.
Pageof 4